Healio: Eyevensys closes on $30 million Series B financing
Healio: Eyevensys closes on $30 million Series B financing
Healio: Eyevensys closes on $30 million Series B financinghttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg150150EyevensysEyevensyshttps://eyevensys.com/wp-content/themes/crocal/images/empty/thumbnail.jpg
Patricia Zilliox, CEO of Eyevensys discusses closing a $30 million in Series B financing intended for development of EYS606 for the treatment of chronic noninfectious uveitis.